Skip to main content

Table 1 Demographics and co-morbidities of patient groups

From: Splenectomy for hypersplenism with or without preoperative splenic artery embolisation

  Study group (n = 50) Control group (n = 50) p value
Age (years, mean ± SD (range)) 38 ± 8.1 (28–62) 34 ± 7.8 (25–60) 0.893
Gender (n (%)) Male 23 (46) 20 (40) 0.686
Female 27 (54) 30 (60)
Splenic size (cm, mean ± SD (range)) 16.2 ± 3.9 (13–26) 16.4 ± 4.8 (13–25) 0.685
Child-Pugh class (n (%)) A 47 (94) 48 (96)  
B 3 (6) 2 (4)  
C 0 0  
Co-morbidities (n (%)) DM 7 (14) 6 (12) 0.659
Cholestasis 17 (34) 15 (30) 0.365
Hypertension 3 (6) 4 (8) 0.786
CBC (mean ± SD (range))
 Platelet (U/μL) 8500 ± 2444 (6500–18,600) 9200 ± 2765 (6500–17,400) 0.646
 WBCs (U/μL) 2700 ± 549 (1150–3200) 2580 ± 642 (1190–3140) 0.413
 HB (gm/dL) 8.3 ± 0.79 (7.5–10.8) 8.5 ± 0.82 (7.8–10.4) 0.250
Liver function tests (mean ± SD (range))
 ALT (U/μL) 72.8 ± 3.5 (67.2–79.5) 73.4 ± 3.7 (65.8–78.6) 0.359
 AST (U/μL) 70.6 ± 2.1 (66.8–79.2) 71.2 ± 2.9 (67.4–77.9) 0.329
 TB (μmol/L) 23.4 ± 3.3 (18.5–29.4) 22.8 ± 3.2 (18.9–28.6) 0.257
  1. OS open splenectomy, SAE splenic artery embolisation, DM diabetes mellitus, CBC complete blood count, WBC white blood cell, HB haemoglobin, ALT alanine aminotransferase, AST aspartate aminotransferase, TB total bilirubin